Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis
Int J Tuberc Lung Dis
.
2015 Oct;19(10):1261-2.
doi: 10.5588/ijtld.15.0541.
Authors
Rajesh Gupta
1
,
Lawrence J Geiter
2
,
Jeffrey Hafkin
2
,
Charles D Wells
2
Affiliations
1
Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA.
[email protected]
.
2
Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA.
PMID:
26459547
DOI:
10.5588/ijtld.15.0541
No abstract available
Publication types
Letter
Comment
MeSH terms
Electrocardiography / methods*
Humans
Long QT Syndrome / diagnosis*
Tuberculosis, Multidrug-Resistant / drug therapy*